The absence of an apolipoprotem ε4 allele is associated with a more aggressive form of Alzheimer's disease

Annals of Neurology

Volumn 41, Issue 5, 1997, Pages 615-620

  Stern, Yaakov ^a,b   Brandt, Jason ^c   Albert, Marilyn ^d   Jacobs, Diane M ^a,b   Liu, Xinhua ^b   Bell, Karen ^a   Marder, Karen ^a,b   Sano, Mary ^a,b   Albert, Steven ^a,b   Del Castillo Castenada, Caridad ^a   Bylsma, Fred ^d   Tycko, Ben ^a   Mayeux, Richard ^a,b  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; DEGENERATIVE DISEASE; DISEASE COURSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCLONUS; ONSET AGE; PRIORITY JOURNAL; SURVIVAL RATE; CAUSE OF DEATH; ETHNOLOGY; EXTRAPYRAMIDAL SYNDROME; FOLLOW UP; GENETICS; MORTALITY; NEUROFIBRILLARY TANGLE; PATHOLOGY;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BASAL GANGLIA DISEASES; CAUSE OF DEATH; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MYOCLONUS; NEUROFIBRILLARY TANGLES; SURVIVAL RATE;

EID: 0030610520     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410510     Document Type: Article

References (32)

1. van Dujin CM, de Knijff P, Wehnert A, et al. The apolipoprotein E ε2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995; 37:605-610
2. Frisoni GB, Govoni S, Geroldi C, et al. Gene dose ot the ε4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 1995;37:596-604
3. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and competing risks of death and Alzheimer's disease. Neurology 1995;45: 1323-1328
4. Stern Y, Folstein M, Albert M, et al. Multicenter study ot predictors of disease course in Alzheimer disease (the "predictors study"). I. Study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord 1994;7:3-21
5. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944
6. Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment and Parkinson's disease. Neurology 1981;31: 645-650
7. Stern Y, Sano M, Paulson J, Mayeux R. Modified mini-mental state examination: validity and reliability. Neurology 1987; 37(suppl 1):179 (Abstract)
8. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
9. Hachinski VC, Iliff LD, Zhilka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637
10. Stern MB, Hurting HI. The clinical characteristics of Parkinson's disease and parkinsonian syndromes: diagnosis and assessment. In: The comprehensive management of Parkinson's disease. New York: PMA, 1978:3-50
11. Richards M, Marder K, Bell K, et al. Interrater reliability of extrapyramidal signs in a group assessed for dementia. Arch Neurol 1991;48:1147-1149
12. Wechsler D. Wechsler adult intelligence scale-revised. New York: The Psychological Corporation, 1981
13. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486
14. Hixson J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhAI. J Lipid Res 1991;31:545-548
15. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37:254-259
16. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472
17. Draper N, Smith H. Applied regression analysis. 2nd ed. New York: John Wiley, 1981
18. Liu X, Tsai W-Y, Stern Y. A functional decline model for prevalent cohort data. Stat Med 1996;15:1023-1032
19. Feskens EJM, Havekes LM, Kalmijn S, et al. Apolipoprotein ε4 allele and cognitive decline in elderly men. Br Med J 1994;309: 1202-1206
20. Chen JY, Stern Y, Sano M, Mayeux R. Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol 1991;48:1141-1143
21. Van Dijk PT, Dippel DW, Van Der Meulen JH, Habbema JD. Comorbidity and its effect on mortality in nursing home patients with dementia. J Nerv Mental Dis 1996;184:180-187
22. Stern Y, Mayeux R, Chen J, Sano M. Predictors of mortality in Alzheimer's disease. Ann Neurol 1989;26:132 (Abstract)
23. Snowden MB, Bowen JD, Hughes J, Larson EB. Study of Alzheimer's dementia patients with parkinsonian features. J Geriatr Psychiatry Neurol 1995;8:154-158
24. Stern Y, Mayeux R, Sano M, et al. Predictors of disease course in patients with probable Alzheimer's disease. Neurology 1987; 37:1649-1653
25. Chui HC, Lyness S, Sobel E, et al. Prognostic implications of symptomatic behaviors in Alzheimer's disease. In: Boller F, Forette F, Khatchaturian Z, et al. Heterogeneity of Alzheimer's disease. New York: Springer-Verlag, 1992:12-24
26. Mortimer JA, Ebbitt B, Jun SP, Finch MD. Predictors of cognitive and functional decline in patients with probable Alzheimer's disease. Neurology 1992;42:1689-1696
27. Stern Y, Brandt J, Albert M, et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission and death in Alzheimer's disease: prospective analyses from the predictors study. Neurology 1995;45:1-10
28. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 1993;43:2184-2188
29. Richards M, Stern Y, Marder K, et al. Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals. Ann Neurol 1993;33:267-274
30. Kokmen E, Ozsarfati Y, Beard CM, et al. Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. J Clin Epidemiol 1996;49:79-83
31. Marder K, Richards M, Bello J, et al. Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. Arch Neurol 1995;52:146-151
32. Marder K, Bello J, Sano M, et al. Progression of Alzheimer's disease over four years in patients with silent stroke. Ann Neurol 1994;36:269 (Abstract)